Related Experiment Video
Updated: Sep 29, 2026

Flow Cytometric Isolation of Primary Murine Type II Alveolar Epithelial Cells for Functional and Molecular Studies
Published on: December 26, 2012
Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases
A M Vignola1, P Chanez, G Chiappara
1Istituto di Fisiopatologia Respiratoria, C.N.R., Palermo, Italy.
Abstract:
Asthma and chronic bronchitis are associated with airway remodelling, and airway macrophages are present in bronchial inflammation. TGF-beta and fibronectin released by alveolar macrophages possess a fibrogenic potency. The potential role of alveolar macrophages in airway remodelling was studied in asthma and chronic bronchitis by the release of TGF-beta and fibronectin. Alveolar macrophages were isolated by bronchoalveolar lavage in 14 control subjects, 14 asthmatics and 14 chronic bronchitics. The spontaneous and lipopolysaccharide (LPS)- or concanavalin A (Con A)-induced release of TGF-beta and fibronectin was measured by ELISA. Alveolar macrophages from chronic bronchitics spontaneously release greater amounts of TGF-beta and fibronectin than those from asthmatic and control subjects. Alveolar macrophages from asthmatics release greater amounts of TGF-beta and fibronectin than those from control subjects. The spontaneous release of TGF-beta is significantly correlated with that of fibronectin. Fibronectin release was significantly reduced after LPS stimulation, and TGF-beta release was significantly increased after LPS stimulation, except in chronic bronchitis patients. Con A increased the release of TGF-beta in cells from normal subjects. This study suggests that activated macrophages play a role in airway remodelling in chronic bronchitis and to a lesser extent in asthma.
Insights
Activated macrophages in the airways contribute to airway remodeling in chronic bronchitis and asthma. These cells release transforming growth factor-beta (TGF-beta) and fibronectin, key proteins involved in tissue scarring and structural changes.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Immunology
Background:
- Asthma and chronic bronchitis are linked to airway remodeling.
- Airway macrophages are implicated in bronchial inflammation.
- Alveolar macrophages release fibrogenic factors like TGF-beta and fibronectin.
Purpose of the Study:
- To investigate the role of alveolar macrophages in airway remodeling in asthma and chronic bronchitis.
- To quantify the release of TGF-beta and fibronectin by alveolar macrophages in these conditions.
Main Methods:
- Alveolar macrophages were isolated from control, asthmatic, and chronic bronchitis patients via bronchoalveolar lavage.
- Spontaneous and stimulated (LPS or Con A) release of TGF-beta and fibronectin was measured using ELISA.
Main Results:
- Macrophages from chronic bronchitis patients showed higher spontaneous release of TGF-beta and fibronectin compared to asthmatics and controls.
- Macrophages from asthmatics released more TGF-beta and fibronectin than controls.
- TGF-beta and fibronectin release were correlated.
- LPS stimulation differentially affected TGF-beta and fibronectin release, with exceptions in chronic bronchitis.
- Con A increased TGF-beta release in control subjects.
Conclusions:
- Activated alveolar macrophages play a significant role in airway remodeling, particularly in chronic bronchitis and to a lesser extent in asthma.
- The study highlights the fibrogenic potential of macrophages in chronic airway diseases.
More Related Videos
Related Concept Videos
Breathing
TGF - β Signaling Pathway
Alveoli and Alveolar Ducts
Tuberculosis
Chronic Inflammation: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

